| Literature DB >> 31015885 |
Yufeng Chen1, Huilin Yang1, Lianfang Zhang1, Yue Wang2, Jun Zou1.
Abstract
Objective: This study aimed to investigate if the presence of Modic changes (MCs) was correlated with lower back pain (LBP) and LBP-related disability in patients who underwent nonsurgical treatment.Entities:
Mesh:
Year: 2019 PMID: 31015885 PMCID: PMC6444235 DOI: 10.1155/2019/8185316
Source DB: PubMed Journal: Pain Res Manag ISSN: 1203-6765 Impact factor: 3.037
Fundamental characteristics of the three groups before treatment.
| Group A | Group B | Group C | |
|---|---|---|---|
| Number | 50 | 31 | 48 |
| Male | 22 (44%) | 13 (42%) | 21 (44%) |
| Female | 28 (56%) | 18 (58%) | 27 (56%) |
| Average age (range) | 40.5 (25–62) | 41.6 (21–65) | 44.5 (24–67) |
| BMI | 20.4 ± 1.0 | 20.1 ± 0.9 | 20.5 ± 0.9 |
| Smoking | 13 (26.0%) | 8 (25.8%) | 14 (29.2%) |
| Heavy work | 29 (58%) | 18 (58.1%) | 28 (58.3%) |
| Involved disc | |||
| L3–4 | 3 | 3 | |
| L4–5 | 13 | 20 | |
| L5–S1 | 15 | 25 |
Figure 1Illustration of Modic type I changes. (a) Hypointense changes on T1-weighted images at the L4 vertebral lower endplate and L5 vertebral body upper endplate. (b) Hyperintense changes on T2-weighted images at the L4 vertebral lower endplate and L5 vertebral upper endplate.
Figure 2Illustration of Modic type II changes. (a) Hyperintense changes on T1-weighted images at the L4 vertebral lower endplate and L5 vertebral body upper endplate. (b) Hyperintense changes on T2-weighted images at the L4 vertebral lower endplate and L5 vertebral upper endplate.
Scores of ODI and VAS for the three groups before treatment.
| Group A | Group B | Group C | |
|---|---|---|---|
| Number | 50 | 31 | 48 |
| Male : female | 22 : 28 | 13 : 18 | 21 : 27 |
| ODI | 22.7 ± 4.6 | 22.0 ± 5.2 | 22.7 ± 5.1 |
| VAS | 6.3 ± 1.6 | 6.4 ± 1.8 | 6.3 ± 2.2 |
Scores of ODI and VAS, as well as corresponding improved rates for the three groups 3 months after treatment.
| Group A | Group B | Group C |
| |
|---|---|---|---|---|
| Number | 50 | 31 | 48 | |
| ODI | 8.9 ± 2.1 | 9.3 ± 2.4 | 11.8 ± 2.9 | |
| ODI improvement rate (%) | 60.8 | 57.7 | 48.0 | 0.014 |
| VAS | 2.4 ± 0.8 | 2.9 ± 0.8 | 3.4 ± 1.2 | |
| VAS improvement rate (%) | 61.9 | 54.7 | 46.0 | 0.023 |
Statistically significant.
Scores of ODI and VAS and corresponding improved rates for the three groups 6 months after treatment, as well as comparing with the results in Table 3.
| Group A | Group B | Group C | |
|---|---|---|---|
| Number | 50 | 31 | 48 |
| ODI | 8.5 ± 2.0 | 7.8 ± 2.8 | 11.3 ± 2.6 |
| ODI improvement rate (%) | 4.5 | 16.1 | 4.2 |
|
| 0.130 | 0.037 | 0.178 |
| VAS | 2.3 ± 0.8 | 2.5 ± 1.2 | 3.2 ± 0.9 |
| VAS improvement rate (%) | 4.2 | 13.8 | 5.9 |
|
| 0.097 | 0.026 | 0.082 |
Statistically significant.